Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Alcon Research Ltd
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
Nepafenac Once Daily for Macular Edema - Study 2 A naponta egyszer, makula ödémára alkalmazott nepafenak – 2. klinikai vizsgálat
To demonstrate superiority of Nepafenac Ophthalmic Suspension, 0.3% dosed once daily relative to Nepafenac Vehicle based upon clinical outcomes among diabetic subjects following cataract surgery. ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
To evaluate the safety and efficacy of AL-8309B Ophthalmic Solution versus vehicle administered as a topical ocular drop for the treatment of geographic atrophy secondary to AMD.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
A multi-center, double-masked study of the safety and efficacy of Travoprost APS compared to TRAVATAN in patients with open-angle glaucoma or ocular hypertension
To compare the efficacy and safety of Travoprost APS to TRAVATAN Solution, both dosed once-daily in the evening, in patients with open-angle glaucoma or ocular hypertension
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients with Open-Angle Glaucoma or Ocular Hypertension
The primary objective of this study is to describe the safety of polyquaternium-preserved DuoTrav APS dosed once daily for 12 months, in patients with open angle glaucoma or ocular hypertension.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
RTH258 6 mg in patients with retina damage such as growth of abnormal blood vessels RTH258 6 mg em doentes com danos na retina tais como crescimento anormal de vasos sanguíneos
To demonstrate that RTH258 6 mg is not inferior to aflibercept 2 mg with respect to the change in best-corrected visual acuity (BCVA) from Baseline to Week 48
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients with Open-Angle Glaucoma or Ocular Hypertension
To compare the efficacy and safety of Travoprost APS to TRAVATAN both dosed once-daily in the evening, in patients with open-angle glaucoma or ocular hypertension
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
Safety and eye pressure lowering effect of Brinz/Brim eye drops, compared to Brinzolamide and Brimonidine given separately in patients with increased eye pressure (ocular hypertension) or with associated changes to the nerve inside the eye (glaucoma)
Brinzolamide 10 mg/mL / brimonidine 2 mg/mL eye drops, suspension is superior to brinzolamide 10 mg/mL eye drops, suspension, with respect to IOP-lowering efficacy, and brinzolamide 10 mg/mL / brim...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
Estudio multicéntrico de la pigmentación en la red trabecular después de dos años de tratamiento con TRAVATAN 0,004% solución oftálmica. A multicenter study of the pigmentation in the trabecular meshwork after two year of treatment with TRAVATAN 0.004% ophthalmic solution
To assess the pigmentation in the trabecular meshwork in subjects that have been treated for at least two years with TRAVATAN 0.004% compared to subjects without exposure (or < 1 month) to prostagland...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes
To evaluate the safety and efficacy of topical Moxidex for the treatment of patients with acute otitis media with tympanostomy tubes (AOMT); To demonstrate the therapeutic superiority of Moxidex rel...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Alcon Research Ltd
MAJ Il y a 4 ans
Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of exudative age-related macular degeneration
To assess the safety and tolerability of treatment following a single intravitreal administration of ESBA1008 compared to Lucentis in patients with exudative AMD
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3